In this free webinar, learn how to identify sources of variability in bioassay method transfers and describe how laboratory conditions, instrumentation, reagents and personnel technique impact ...
Preliminary results of a Cancer Research UK phase I trial combining the dinitrobenzamide prodrug CB1954 (tretazicar) and the NQO2 substrate EP-0152R (caricotamide) intravenously (IV) every 3 weeks No ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results